HIV

Influential task force urges payers to cover PrEP for HIV
Influential task force urges payers to cover PrEP for HIV
Healthcare Dive
HIV
PrEP
Gilead Sciences
Truvada
Affordable Care Act
US Preventive Services Task Force
Flag link:
Daily HIV prevention pill urged for healthy people at risk
Daily HIV prevention pill urged for healthy people at risk
Stat
HIV
PrEP
Truvada
Gilead Sciences
Flag link:
J&J passes key milestone in HIV vaccine trial
J&J passes key milestone in HIV vaccine trial
Pharmaforum
JNJ
Janssen
clinical trials
vaccines
HIV
Imbokodo
Flag link:
Medicare decides against tighter management of HIV drugs
Medicare decides against tighter management of HIV drugs
Biopharma Dive
HHS
Medicare
HIV
Medicare Part D
Flag link:
Gilead defends Truvada pricing during House hearing
Gilead defends Truvada pricing during House hearing
BioCentury
Gilead Sciences
Truvada
HIV
drug pricing
US Congress
Flag link:
Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says
Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says
Stat
Gilead Sciences
AIDS
HIV
generics
competition
Flag link:
Legal Decision Could Open the Doors for Truvada Generic Competition One Year Early, Gilead Says
Legal Decision Could Open the Doors for Truvada Generic Competition One Year Early, Gilead Says
BioSpace
Gilead Sciences
HIV
Truvada
competition
Teva Pharmaceutical
Flag link:
Gilead patent cliff looms as Teva plans generic Truvada launch
Gilead patent cliff looms as Teva plans generic Truvada launch
Pharmaforum
Gilead Sciences
HIV
Truvada
generics
Teva Pharmaceuticals
Flag link:
Gilead will donate meds for US push to end HIV epidemic
Gilead will donate meds for US push to end HIV epidemic
Yahoo/AP
Gilead Sciences
HIV
donations
Truvada
Flag link:
ViiV Submits NDA for Once-Per-Month HIV Injectable
ViiV Submits NDA for Once-Per-Month HIV Injectable
BioSpace
ViiV Healthcare
FDA
HIV
HIV-1
cabotegravir
rilpivirine
Flag link:
Department of Justice Reviewing Gilead and CDC’s HIV Patents
Department of Justice Reviewing Gilead and CDC’s HIV Patents
BioSpace
DOJ
patents
Gilead Sciences
CDC
HIV
Truvada
Flag link:
Going viral? J&J tries to spark a Twitterstorm for the latest data on its HIV med
Going viral? J&J tries to spark a Twitterstorm for the latest data on its HIV med
Endpoints
JNJ
HIV
Symtuza
social media
twitter
Flag link:
GSK wins U.S. nod for two-drug HIV combination
GSK wins U.S. nod for two-drug HIV combination
Yahoo/Reuters
GSK
FDA
HIV
Dovato
Flag link:
Gilead sees Descovy as successor to Truvada for HIV PrEP
Gilead sees Descovy as successor to Truvada for HIV PrEP
BioCentury
Gilead Sciences
Descovy
Truvada
HIV
PrEP
Flag link:
ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
Pharmaceutical Business Review
ViiV Healthcare
Dolutegravir
rilpivirine
JNJ
Janssen
HIV
Flag link:
Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%
Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%
Motley Fool
Gilead Sciences
GS-6207
HIV
Flag link:
Gilead raises prices on top-selling HIV treatments
Gilead raises prices on top-selling HIV treatments
Biopharma Dive
Gilead Sciences
drug pricing
HIV
Flag link:
Gilead shares early clinical data on HIV capsid inhibitor
Gilead shares early clinical data on HIV capsid inhibitor
Fierce Biotech
Gilead Sciences
HIV
GS-6207
clinical trials
Flag link:
Monthly shots control HIV as well as daily pills in two big studies
Monthly shots control HIV as well as daily pills in two big studies
Stat
HIV
AIDS
JNJ
Janssen
ViiV Healthcare
cabotegravir
Edurant
Flag link:
Gilead scores key HIV data as Descovy proves non-inferior to Truvada
Gilead scores key HIV data as Descovy proves non-inferior to Truvada
BioPharma Dive
Gilead Sciences
HIV
Descovy
Truvada
clinical trials
Flag link:

Pages